TEMOREL 100 MG

About

Temozolomide, known as Temorel, is an oral alkylating agent used in the treatment of certain brain tumors. It is a prodrug that undergoes rapid chemical conversion at physiological pH to its active metabolite, monomethyl triazenoimidazole carboxamide (MTIC). MTIC then methylates DNA at various sites, primarily at the O6 and N7 positions of guanine. This methylation leads to DNA damage and subsequent apoptosis (programmed cell death) in rapidly dividing cancer cells. Its ability to cross the blood-brain barrier makes it particularly effective against primary and metastatic brain tumors.

Temorel is a crucial component of chemotherapy regimens for aggressive cancers such as glioblastoma multiforme and anaplastic astrocytoma, improving progression-free survival and overall survival in these challenging malignancies. It is often used in combination with radiotherapy for newly diagnosed glioblastoma. The oral administration offers convenience for patients, while its targeted DNA damaging effect provides a potent therapeutic strategy against brain tumors.

Uses

• Glioblastoma Multiforme (newly diagnosed and refractory)
• Anaplastic Astrocytoma (refractory)
• Other malignant gliomas (off-label)
• Neuroendocrine tumors (off-label)

Directions For Use

Take orally on an empty stomach, typically once daily for a specified number of days in a cycle, as directed by your oncologist.

Benefits

• Effective against aggressive brain tumors
• Crosses the blood-brain barrier efficiently
• Can be used in combination with radiotherapy
• Improves progression-free survival
• Offers an oral administration option
• Provides targeted DNA damage to cancer cells

Side Effects

• Nausea and vomiting
• Fatigue
• Headache
• Constipation
• Myelosuppression (low blood counts)
• Anorexia
• Rash
• Alopecia
• Dizziness
• Diarrhea
• Infections
• Thrombocytopenia

Safety Measures

• Alcohol - Avoid or limit alcohol due to potential for increased nausea, vomiting, and liver strain, especially during chemotherapy.
• Pregnancy - Contraindicated due to significant genotoxic and teratogenic potential; use effective contraception during and after treatment.
• Breastfeeding - Not recommended; discontinue breastfeeding during treatment due to potential harm to the infant from drug excretion in milk.
• Liver - Use with caution in patients with severe hepatic impairment; monitor liver function tests closely throughout the treatment period.
• Kidney - Use with caution in patients with severe renal impairment; monitor renal function regularly.
• Lung - Monitor for pulmonary toxicity, including interstitial pneumonitis, though rare; report any new or worsening respiratory symptoms promptly.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.